Skip to content

National HIV Guidelines Ethiopia

National HIV Guidelines Ethiopia
🏥 Ethiopian Ministry of Health 📅 Year: 2018 📄 Format: PDF ⬇️ Downloads: 37

What this document is

This page hosts the full PDF of the Federal Ministry of Health’s National Guidelines for Comprehensive HIV Prevention, Care and Treatment, dated February 2018. The file runs to 243 pages. It brings HIV testing, prevention, antiretroviral therapy (ART), co-infections, service delivery and programme management into one consolidated national guideline.

Background

The foreword traces Ethiopia’s ART programme from its start in 2003 and the launch of free ART in 2005. The first national ARV guidelines were issued in 2003 and revised in 2005, 2008 and 2014; this edition revised them again. It cites a 2017 estimate of 722,248 people living with HIV in Ethiopia, all of whom need ART, against about 420,000 then taking it, and it gives weight to task shifting and to decentralising care to health centres.

Testing and prevention

Chapter 2 covers HIV testing services: approaches, procedures, retesting and testing in specific populations, plus targeted methods including index case testing, respondent-driven testing, HIV self-testing, risk screening and partner services. It also covers quality management, ethical and legal considerations, linkage to care, post-exposure prophylaxis after occupational exposure and after sexual assault, combination prevention, and care of HIV-exposed infants.

Starting and monitoring ART

Chapter 3 sets out the general care package, preparing people for ART, and when to start treatment in adults and adolescents, pregnant and breastfeeding women, children, people with TB or drug-resistant TB, and people co-infected with hepatitis B. It then covers first-line regimens, what to expect in the first months, clinical and laboratory monitoring, drug toxicity and substitution, re-engaging people who stopped treatment, treatment failure, second-line regimens for adults and children, and second-line ART at health centre level.

Co-infections and opportunistic diseases

Chapter 4 covers co-trimoxazole preventive therapy, TB, pneumonia including pneumocystis pneumonia, gastrointestinal problems, toxoplasmosis, cryptococcal infection, neuropathy, skin conditions, visceral leishmaniasis and screening for other conditions.

Service delivery and programme management

Chapter 5 covers differentiated service delivery including appointment spacing, linkage from testing to care, disclosure, adherence, task shifting, decentralisation, integration with other services, services for adolescents, quality improvement, supply management and laboratory services. Chapters 6 and 7 give guidance for programme managers and set out indicators, data flow, data quality and supportive supervision.

Annexes and a note on the date

The annexes include growth curves, MUAC measurement, ARV dosing for adults and children, paediatric formulations, adverse event grading tables, TB screening tools, a high viral load follow-up form and a mental health screening tool. This is the February 2018 edition. Recommended ART regimens have changed since then, so check drug choices against current Ministry of Health guidance before using them for patient care.

Related documents in the Hepius library

See also the National Guideline for Prevention of Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B (November 2021) and the Guideline for Diagnosis, Treatment and Prevention of Leishmaniasis in Ethiopia, which covers visceral leishmaniasis in people living with HIV.

Download PDF Free to download — no registration required

Get new Ethiopian clinical guidelines by email

One short message when a new national guideline, protocol or standard is added to this library. The download above stays free either way.

No spam, unsubscribe any time. Privacy policy.

Related documents

Other guidelines and protocols on the same subject.

Browse the full document library →